Browsing NTNU Open by Author "Killingberg, Kristin Toftaker"
Now showing items 1-10 of 10
-
Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC
Stokke, Kristin; Halvorsen, Tarje Onsøien; Grønberg, Bjørn Henning; Saltvedt, Ingvild; Jordhøy, Marit Slaaen; Kirkevold, Øyvind; Killingberg, Kristin Toftaker; Sandvei, Marie Søfteland (Peer reviewed; Journal article, 2022)Background: There is a lack of tools for selecting patients with advanced lung cancer who benefit the most from systemic treatment. Patient-reported physical function (PRPF) has been identified as a prognostic factor in ... -
Effect of FDG PET-CT for Staging and Radiotherapy Planning – a Comparison of Cohorts from Two Randomized Trials of Thoracic Radiotherapy in Limited-Stage SCLC
Graabak, Gustav; Killingberg, Kristin Toftaker; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien (Peer reviewed; Journal article, 2024) -
Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer
Levin, Nina; Killingberg, Kristin Toftaker; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien (Peer reviewed; Journal article, 2024) -
High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial
Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Fløtten, Øystein; Brustugun, Odd; HORNSLIEN, KJERSTI; Madebo, Tesfaye; Langer, Seppo Wang; Schytte, Tine; Nyman, Jan; Risum, Signe; Tsakonas, Georgios; Engleson, Jens; Halvorsen, Tarje Onsøien (Journal article; Peer reviewed, 2021)High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial -
Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer
Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Brustugun, Odd Terje; HORNSLIEN, KJERSTI; Madebo, Tesfaye; Langer, Seppo W.; Schytte, Tine; Risum, Signe; Tsakonas, Georgios; Nyman, Jan; Engleson, Jens; Grønberg, Bjørn Henning (Peer reviewed; Journal article, 2022)Objectives In a randomized phase II trial, twice daily (BID) thoracic radiotherapy (TRT) of 60 Gy/40 fractions improved survival compared with 45 Gy/30 fractions in limited stage small-cell lung cancer (LS SCLC). Notably, ... -
Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer
Stokke, Kristin; Sandvei, Marie Søfteland; Grønberg, Bjørn Henning; Jordhøy, Marit Slaaen; Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien (Peer reviewed; Journal article, 2022)Background: The Glasgow prognostic score (GPS) is an established inflammatory prognostic index in cancer patients. Most studies have only measured GPS at baseline (B-GPS). Effective cancer therapy may reduce inflammation, ... -
Radiotherapy of Lung Cancer
Graabak, Gustav (Doctoral theses at NTNU;2024:254, Doctoral thesis, 2024)Strålebehandling av lungekreft Lungekreft er nest hyppigst og forårsaker flest dødsfall av alle kreftformer. Det er to hovedtyper lungekreft: ikke-småcellet lungekreft og småcellet lungekreft (SCLC). SCLC er den mest ... -
Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC
Halvorsen, Tarje Onsøien; Stokke, Kristin; Killingberg, Kristin Toftaker; Raj, Sunil Xavier; Sørhaug, Sveinung; Brustugun, Odd Terje; Fløtten, Øystein; Helbekkmo, Nina; Hornslien, Kjersti; Madebo, Tesfaye; Fluge, Sverre; Grønberg, Bjørn Henning (Peer reviewed; Journal article, 2020)Objectives: Two phase III trials show that maintenance pemetrexed therapy after platinum-doublet chemotherapy prolongs overall survival (OS) and progression free survival (PFS) in advanced non-squamous non-small-cell lung ... -
Treatment Outcomes of Older Participants in a Randomized Trial Comparing Two Schedules of Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC
Killingberg, Kristin Toftaker; Grønberg, Bjørn Henning; Jordhøy, Marit Slaaen; Kirkevold, Øyvind; Halvorsen, Tarje Onsøien (Peer reviewed; Journal article, 2023)Introduction Half of the patients with limited-stage SCLC (LS SCLC) are above or equal to 70 years old, but they account for less than 20% of participants in most trials. Comorbidities and reduced organ and physical ... -
Twice-daily thoracic radiotherapy in limited stage small-cell lung cancer
Killingberg, Kristin Toftaker (Doctoral theses at NTNU;2023:156, Doctoral thesis, 2023)Norsk sammendrag Lungekreft er den kreftformen som forårsaker flest dødsfall. Lungekreft deles inn i to hovedtyper, ikke-småcellet (NSCLC) og småcellet lungekreft (SCLC). SCLC utgjør 13-15% av tilfellene og kjennestenges ...